Using Neuroimaging to Explore the Alzheimer’s Disease and Related Dementia (AD/ADRD)
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neurodegenerative Diseases".
Deadline for manuscript submissions: 20 December 2024 | Viewed by 40
Special Issue Editor
2. Georgia Institute of Technology, Emory University, Atlanta, GA 30303, USA
3. Department of Computer Science, Georgia State University, Atlanta, GA 30303, USA
Interests: signal processing; advanced machine learning; neuroimaging
Special Issue Information
Dear Colleagues,
Neuroimaging tools including MRI, functional MRI, diffusion MRI, PET, and SPECT are pivotal in determining imaging biomarkers for the early detection, staging, diagnostic and prognostic classification, progression prediction, and therapeutic assessment of Alzheimer’s disease and related dementia (AD/ADRD). Previous neuroimaging studies have demonstrated differential patterns of atrophy and hypometabolism in AD and ADRDs including frontotemporal dementia, vascular dementia, Parkinson’s disease, Huntington’s disease, Lewy body dementia, and Creutzfeldt–Jakob disease. In order to advance dementia science, this topic welcomes the submission of high-quality original research, reviews, clinical case studies, and perspectives on the use of neuroimaging to understand the underlying anatomical and functional brain changes in AD/ADRD. The topics of interest include, but are not limited to, the development of new innovative neuroimaging modalities, data processing and analytical methodologies for AD/ADRD, the development of novel clinical applications to increase the accuracy of differential diagnosis and enhance the preclinical detection rates of AD/ADRD, and interventional AD/ADRD studies to benefit at-risk individuals.
Dr. Anees Abrol
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer's disease (AD)
- Alzheimer's disease and related dementia (ADRD)
- neuroimaging
- preclinical AD/ADRD
- preclinical biomarkers
- early diagnosis
- precision medicine
- magnetic resonance imaging (MRI)
- structural MRI (sMRI)
- functional MRI (fMRI)
- diffusion-weighted MRI (dMRI)
- positron emission tomography (PET)
- single-photon emission computed tomography (SPECT)
